Packaging | September 22, 2021
SCHOTT expands tubing capacity in India
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Subscribe To Our Newsletter & Stay Updated
